Aurinia Pharmaceuticals Stock Performance
as on November 2, 2026 at 2:16 pm IST
Day's Low
Day's High
$16.48$17.04
1.02%
Downside
2.34%
Upside

52 Week's Low
52 Week's High
$12.79$19.25
23.18%
Downside
15.62%
Upside

Aurinia Pharmaceuticals share price movements today
- Previous Close
- $17.21
- Open
- $16.77
- Volume
- 632.1K
- Market Cap
- $2.2B
- Day's Low - High
- $16.48 - $17.04
- 52 Week Low - High
- $12.79 - $19.25
Aurinia Pharmaceuticals Historical Returns
- 1 Month Return
- + 5.18 %
- 3 Month Return
- + 11.9 %
- 1 Year Return
- + 26.42 %
- 3 Year Return
- + 111.29 %
- 5 Year Return
- -47.97 %
Aurinia Pharmaceuticals Stock Fundamentals & Key Indicators
Check Aurinia Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.2B
EPS (TTM)
2.37
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
7.03
Industry PE ratio
-7.37
PEG Ratio
0.02
EBITDA
195.8M
Revenue (TTM)
321.7M
Profit Margin
90.73%
Return On Equity TTM
51.92%
Aurinia Pharmaceuticals vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurinia Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $2.2B | -47.97% | 7.03 | 90.73% | 0.00% | |
| Neutral | $88.5B | -36.40% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 208.09% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 45.26% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Aurinia Pharmaceuticals Stock including INR - Dollar returns
The Aurinia Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Aurinia Pharmaceuticals investment value today
Current value as on today
₹1,35,296
Returns
₹35,296
(+35.3%)
Returns from Aurinia Pharmaceuticals Stock
₹26,424 (+26.42%)
Dollar Impact
₹8,872 (+8.87%)
Analyst Recommendation on Aurinia Pharmaceuticals Stock
Based on 2 analysts
50.00%
Buy
50.00%
Hold
0.00%
Sell
Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for Aurinia Pharmaceuticals. Average target price of $18
Aurinia Pharmaceuticals Share Price Target
Get share price movements and forecasts by analysts on Aurinia Pharmaceuticals.
What analysts predicted
7.5%UPSIDE
Target Price
$18
Current Price
$16.65
Analyzed by
2 Analysts
High
$21
Target
$18.00
Low
$16
Aurinia Pharmaceuticals target price $18, a slight upside of 7.5% compared to current price of $16.65. According to 2 analysts rating.
Indian Investors' Interest in Aurinia Pharmaceuticals Stock
Search interest for Aurinia Pharmaceuticals Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Aurinia Pharmaceuticals Quarterly Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Annual Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Quarterly Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Annual Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals News & Key Events

Today's Timeline - 15 October
Wed, 04:13 PM
-Aurinia Pharmaceuticals to present new LUPKYNIS data at ACR and ASN conferences, enhancing understanding of lupus nephritis treatment.
Insights on Aurinia Pharmaceuticals
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 8 quarters, 59.86M → 83.69M (in $), with an average increase of 4.6% per quarter
POSITIVE IMPACTPrice Rise

In the last 3 months, AUPH stock has moved up by 11.9%
NO EFFECTAgainst Peers

In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 100.0%
NO EFFECTAgainst Peers

In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 689.9%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 37.41M → 31.70M (in $), with an average decrease of 15.3% per quarter
About Aurinia Pharmaceuticals
| Organisation | Aurinia Pharmaceuticals |
| Headquarters | #140, 14315 – 118 Avenue, Edmonton, AB, T5L 4S6, CA |
| Industry | Biotechnology |
| CEO | Kevin C. Tang |
Key Management of Aurinia Pharmaceuticals
Name | Title |
|---|---|
Mr. Kevin C. Tang | Chairman & CEO |
Mr. Stephen P. Robertson | Chief Legal Officer, Corporate Secretary & Chief Compliance Officer |
Mr. Peter S. Greenleaf M.B.A. | Consultant |
Mr. Ryan Cole | Chief Operating Officer |
Mr. Thomas Wei | Chief Scientific Officer |
Mr. Stewart M. Kroll | Chief Development Officer |
FAQs
What is Aurinia Pharmaceuticals share price today?
Aurinia Pharmaceuticals share price today is $16.65 as on at the close of the market. Aurinia Pharmaceuticals share today touched a day high of $17.04 and a low of $16.48.
What is the 52 week high and 52 week low for Aurinia Pharmaceuticals share?
Aurinia Pharmaceuticals share touched a 52 week high of $19.25 on and a 52 week low of $12.79 on . Aurinia Pharmaceuticals stock price today i.e. is closed at $16.65,which is 13.51% down from its 52 week high and 30.18% up from its 52 week low.
What is Aurinia Pharmaceuticals's market capitalisation today?
Aurinia Pharmaceuticals market capitalisation is $0.00T as on .
How to invest in Aurinia Pharmaceuticals Stock (AUPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aurinia Pharmaceuticals on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Aurinia Pharmaceuticals Stock (AUPH) from India?
Indian investors can start investing in Aurinia Pharmaceuticals (AUPH) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Aurinia Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aurinia Pharmaceuticals share’s latest price of $16.65 as on November 2, 2026 at 8:46 am IST, you will get 0.6006 shares of Aurinia Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Aurinia Pharmaceuticals has given to Indian investors in the last 5 years?
Aurinia Pharmaceuticals stock has given -47.97% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?